A CR-UK Phase I Trial of LY3143921

NCT03096054 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

69

Enrollment

OTHER

Sponsor class

Conditions

A. Colorectal Cancer
B. High Grade Serous Ovarian Cancer
C. Non Small-cell Lung Cancer (squamous Cell Variant)
D. Squamous Carcinoma of the Oesophagus
E. Squamous Carcinoma of the Head and Neck (HPV Negative)
F. Urothelial Cancer
G. Breast Cancer (triple Negative Type)
H. Pancreatic Cancer

Interventions

DRUG: LY3143921 hydrate

Sponsor

Cancer Research UK